Home›Stock Screener›Lupin›Quarterly Results

Lupin Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹1,469 Cr
QMar 2026
Quarterly Results

In Mar 2026, Lupin (LUPIN) reported revenue ₹7,533 Cr and net profit ₹1,469 Cr — revenue +34.1% YoY. Compare with LUPIN fair value to assess whether the stock is under or overvalued.

LUPIN Quarterly Results — Revenue, Profit & EPS Highlights

Lupin latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Lupin share price chart.

  • Revenue of ₹7,533 Cr in Mar 2026 (+8.8% vs Sept 2025, +34.1% vs Mar 2025)
  • Net Profit of ₹1,469 Cr in Mar 2026 (-1.1% vs Sept 2025, +87.9% vs Mar 2025)
  • EBITDA of ₹2,412 Cr in Mar 2026 (+8.9% vs Sept 2025)
  • Operating Margin of 31.0% in Mar 2026 (+0.0pp vs Sept 2025)
  • Earnings Per Share of ₹34.83 in Mar 2026 (+7.6% vs Sept 2025)

Lupin Quarterly Results — Revenue, EBITDA, Net Profit & EPS

LUPIN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 7,533 6,921 5,619 6,243 7,215 8.8% 34.1%
Net Profit (₹ Cr) 1,469 1,485 782 1,222 1,181 - -
EBITDA (₹ Cr) 2,412 2,215 1,273 1,702 1,883 - -
EPS (₹) 34.83 32.36 16.93 26.70 25.74 - -
Operating Margin (%) 31.0% 31.0% 22.0% 26.0% 25.0% - -

LUPIN Share Price Trend — 1-Year Movement Across Quarterly Results

Lupin 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore LUPIN stock price history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 19.5%
EBITDA Margin 32.0%
Operating Margin 31.0%
ROE (Annual) 26.2%

Balance Sheet Highlights

Total Assets ₹38,365 Cr
Total Equity ₹22,448 Cr
Current Assets ₹24,027 Cr
Current Liabilities ₹3,200 Cr

Cash Flow Analysis

Operating Cash Flow ₹3,000 Cr
Investing Cash Flow ₹-4,172 Cr
Financing Cash Flow ₹1,732 Cr
Net Cash Flow ₹560 Cr

Current Market Data

Current Price ₹2276.40
Exchange NSE
Last Updated May 27, 2026

Revenue Trend (₹ Cr)

Jun 2025 6,243
Mar 2025 5,619
Sept 2025 6,921
Mar 2026 7,533

Net Profit Trend (₹ Cr)

Jun 2025 1,222
Mar 2025 782
Sept 2025 1,485
Mar 2026 1,469

Operating Margin Trend (%)

Jun 2025 26.0%
Mar 2025 22.0%
Sept 2025 31.0%
Mar 2026 31.0%

LUPIN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Lupin latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026 		₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026 		₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026 		₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026 		₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores